Record Third Quarter Revenue
Enerpac Tool Group reported a 6% year-over-year revenue growth, reaching a record third quarter revenue of $159 million since the relaunch in 2019.
Strong Performance in Cortland Biomedical
Cortland Biomedical reported 19% growth, with strong performance from existing products and new product launches.
High Single-Digit Growth in the Americas
The Americas region delivered high single-digit organic growth, driven by demand in aerospace, infrastructure, and nuclear industry services.
Robust Orders and Backlog for DTA
Despite slower ramp-up, DTA's orders are strong, and the backlog is expanding due to successful cross-selling strategies.
Innovation Lab Investment
Enerpac has invested in a new innovation lab with advanced equipment, enhancing the speed and efficiency of product innovation.
Improved Free Cash Flow
Free cash flow increased 24% despite increased capital spending, with the full-year guidance maintained at $85 million to $95 million.